BioVie announces $21M public offering of 21M shares at $1.00 with warrants

BIOVIE INC.

Offering of 21,000,000 common shares (or pre-funded warrants) at $1.00 per share, plus warrants to purchase up to 10,500,000 shares at $1.50.
Gross proceeds ~$21 million; net proceeds for working capital and general corporate purposes.
ThinkEquity is sole placement agent; offering expected to close March 6, 2024.
Pre-funded warrants exercisable at $0.0001 per share; common warrants exercisable at $1.50 for 5 years.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIOVIE INC. entered into Agreement with ThinkEquity LLC valued at approximately $21,000,000 million (effective 2024-03-04).

Action: entry
Agreement: equity purchase
Counterparty: ThinkEquity LLC
Value: approximately $21,000,000 million
Effective: 2024-03-04

Exact text from the filing

On March 4, 2024, BioVie Inc. (the “ Company ”) entered into a placement agent agreement (the “ Agreement ”) with ThinkEquity LLC, as the placement agent (the “ Placement Agent ”), in connection with the issuance and sale (the “ Offering ”) directly to various investors (the “ Investors ”) of up to 21,000,000 shares

View on SEC.gov

737 material agreements filed in the last 30 days. Browse all material agreements →

BIOVIE INC. filing history →

Source: SEC EDGAR

accession 0001520138-24-000086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.